Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure.

Autor:	López-Azor JC; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., de la Torre N; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain., García-Cosío Carmena MD; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., Caravaca Pérez P; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., Munera C; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain., MarcoClement I; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., Cózar León R; Cardiology Service, University Hospital Virgen Macarena Seville, Spain., Álvarez-García J; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain.; Cardiology Service, University Hospital Ramón y Cajal Madrid, Spain., Pachón M; Cardiology Service, Unidad de Arritmias, Hospital Universitario de Toledo Toledo, Spain., Ynsaurriaga FA; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., Salguero Bodes R; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain., Delgado Jiménez JF; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain.; Faculty of Medicine, Complutense University Madrid, Spain., de Juan Bagudá J; Cardiology Service, Hospital Universitario 12 de Octubre Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) Madrid, Spain.
Jazyk:	angličtina
Zdroj:	Cardiac failure review [Card Fail Rev] 2022 Apr 21; Vol. 8, pp. e13. Date of Electronic Publication: 2022 Apr 21 (Print Publication: 2022).
DOI:	10.15420/cfr.2021.35
Abstrakt:	Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac defibrillators and cardiac resynchronisation therapy, allows monitoring of the nocturnal heart rate, respiratory movements, thoracic impedance, physical activity and the intensity of heart tones, with the aim of predicting major clinical events. Although HeartLogic has demonstrated high sensitivity for the detection of heart failure decompensations, its effects on hospitalisation and mortality in randomised clinical trials has not yet been corroborated. This review details how the HeartLogic algorithm works, compiles available evidence from clinical studies, and discusses its application in daily clinical practice. Competing Interests: Disclosure: RCL declares fees for consultancy work from Boston Scientific. FAY declares fees for consultancy work and presentations from Boston Scientific, Medtronic and Abbott. RSB declares fees for consultancy work from Boston Scientific. JdJB declares fees for consultancy work and presentations from Boston Scientific. All other authors have no conflicts of interest to declare. (Copyright © 2022, Radcliffe Cardiology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu